Growth Expansion Sanity Group is actively expanding across Europe, with recent office growth in Poland, Switzerland, United Kingdom, and broader Western and Eastern Europe. Opportunity for channel partnerships, distribution agreements, and co-marketing with local subsidiaries or distributors in these markets.

Strategic Partnerships Recent and planned collaborations include Curaleaf International and Astrasana Holding AG, indicating openness to manufacturing, distribution, and therapeutics partnerships. This presents a pathway for contract manufacturing, white-labeling, and joint go-to-market programs.

Therapeutic Focus Strong emphasis on medicinal cannabinoids and cannabinoid-based pharmaceuticals alongside consumer wellbeing products. Potential sales opportunities in standardized pharmaceutical-grade formulations, clinical development collaborations, and hospital/clinic channel access.

European Access Large European market access focus with a footprint aiming to expand across key European regions. Ideal for EU-compliant supply, regulatory consulting, and localized selling propositions to healthcare providers, pharmacies, and patient advocacy groups.

Digital & Ops Readiness Investments in tech stack and operations leadership (recent COO appointment) suggest organizational scale-up and data-driven sales enablement. Potential for CRM integration, demand generation partnerships, and BI-driven market analytics to optimize sales targeting.